These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1021 related articles for article (PubMed ID: 28667006)
41. Practical considerations in screening for genetic alterations in cholangiocarcinoma. Bekaii-Saab TS; Bridgewater J; Normanno N Ann Oncol; 2021 Sep; 32(9):1111-1126. PubMed ID: 33932504 [TBL] [Abstract][Full Text] [Related]
42. Promoter hypermethylation is a major event of hMLH1 gene inactivation in liver fluke related cholangiocarcinoma. Limpaiboon T; Khaenam P; Chinnasri P; Soonklang M; Jearanaikoon P; Sripa B; Pairojkul C; Bhudhisawasdi V Cancer Lett; 2005 Jan; 217(2):213-9. PubMed ID: 15617839 [TBL] [Abstract][Full Text] [Related]
43. Mutations of KRAS and TP53 in a minor proportion of Opisthorchis viverrini-associated cholangiocarcinomas in a hamster model. Tangkawattana S; Kaewkes S; Pairojkul C; Tangkawattana P; Sripa B Asian Pac J Cancer Prev; 2008; 9(1):101-6. PubMed ID: 18439086 [TBL] [Abstract][Full Text] [Related]
44. Functions of FGFR2 corrupted by translocations in intrahepatic cholangiocarcinoma. Li F; Peiris MN; Donoghue DJ Cytokine Growth Factor Rev; 2020 Apr; 52():56-67. PubMed ID: 31899106 [TBL] [Abstract][Full Text] [Related]
45. Genome-wide screen identified let-7c/miR-99a/miR-125b regulating tumor progression and stem-like properties in cholangiocarcinoma. Lin KY; Ye H; Han BW; Wang WT; Wei PP; He B; Li XJ; Chen YQ Oncogene; 2016 Jun; 35(26):3376-86. PubMed ID: 26455324 [TBL] [Abstract][Full Text] [Related]
46. Epigenetic regulation in the carcinogenesis of cholangiocarcinoma. Chiang NJ; Shan YS; Hung WC; Chen LT Int J Biochem Cell Biol; 2015 Oct; 67():110-4. PubMed ID: 26100596 [TBL] [Abstract][Full Text] [Related]
48. Exome sequencing of liver fluke-associated cholangiocarcinoma. Ong CK; Subimerb C; Pairojkul C; Wongkham S; Cutcutache I; Yu W; McPherson JR; Allen GE; Ng CC; Wong BH; Myint SS; Rajasegaran V; Heng HL; Gan A; Zang ZJ; Wu Y; Wu J; Lee MH; Huang D; Ong P; Chan-on W; Cao Y; Qian CN; Lim KH; Ooi A; Dykema K; Furge K; Kukongviriyapan V; Sripa B; Wongkham C; Yongvanit P; Futreal PA; Bhudhisawasdi V; Rozen S; Tan P; Teh BT Nat Genet; 2012 May; 44(6):690-3. PubMed ID: 22561520 [TBL] [Abstract][Full Text] [Related]
49. Identification of transcription factors (TFs) and targets involved in the cholangiocarcinoma (CCA) by integrated analysis. Yang L; Feng S; Yang Y Cancer Gene Ther; 2016 Dec; 23(12):439-445. PubMed ID: 27857060 [TBL] [Abstract][Full Text] [Related]
51. Survival analysis of genome-wide profiles coupled with Connectivity Map database mining to identify potential therapeutic targets for cholangiocarcinoma. Lin P; Zhong XZ; Wang XD; Li JJ; Zhao RQ; He Y; Jiang YQ; Huang XW; Chen G; He Y; Yang H Oncol Rep; 2018 Dec; 40(6):3189-3198. PubMed ID: 30272356 [TBL] [Abstract][Full Text] [Related]
52. Methyl-CpG binding protein MBD2 is implicated in methylation-mediated suppression of miR-373 in hilar cholangiocarcinoma. Chen Y; Gao W; Luo J; Tian R; Sun H; Zou S Oncol Rep; 2011 Feb; 25(2):443-51. PubMed ID: 21165562 [TBL] [Abstract][Full Text] [Related]
53. Rectal cancer profiling identifies distinct subtypes in India based on age at onset, genetic, epigenetic and clinicopathological characteristics. Laskar RS; Ghosh SK; Talukdar FR Mol Carcinog; 2015 Dec; 54(12):1786-95. PubMed ID: 25418895 [TBL] [Abstract][Full Text] [Related]
54. Analysis of p53 mutations for a mutational signature in human intrahepatic cholangiocarcinoma. Khan SA; Taylor-Robinson SD; Carmichael PL; Habib N; Lemoine NR; Thomas HC Int J Oncol; 2006 May; 28(5):1269-77. PubMed ID: 16596244 [TBL] [Abstract][Full Text] [Related]
55. Epigenome-wide association study of DNA methylation in panic disorder. Shimada-Sugimoto M; Otowa T; Miyagawa T; Umekage T; Kawamura Y; Bundo M; Iwamoto K; Tochigi M; Kasai K; Kaiya H; Tanii H; Okazaki Y; Tokunaga K; Sasaki T Clin Epigenetics; 2017; 9():6. PubMed ID: 28149334 [TBL] [Abstract][Full Text] [Related]
56. p53 Mutations in human cholangiocarcinoma: a review. Khan SA; Thomas HC; Toledano MB; Cox IJ; Taylor-Robinson SD Liver Int; 2005 Aug; 25(4):704-16. PubMed ID: 15998419 [TBL] [Abstract][Full Text] [Related]
57. Genome-wide DNA methylome variation in two genetically distinct chicken lines using MethylC-seq. Li J; Li R; Wang Y; Hu X; Zhao Y; Li L; Feng C; Gu X; Liang F; Lamont SJ; Hu S; Zhou H; Li N BMC Genomics; 2015 Oct; 16():851. PubMed ID: 26497311 [TBL] [Abstract][Full Text] [Related]
58. p53‑p72‑Δ225‑331‑V31I identified in a cholangiocarcinoma cell line promotes migration and invasiveness via the downregulation of claudin‑1 expression and the activation of Cdc42. Puetkasichonpasutha J; Suthiphongchai T Oncol Rep; 2021 Jan; 45(1):368-378. PubMed ID: 33416138 [TBL] [Abstract][Full Text] [Related]
59. Two classes of intrahepatic cholangiocarcinoma defined by relative abundance of mutations and copy number alterations. Kim YH; Hong EK; Kong SY; Han SS; Kim SH; Rhee JK; Hwang SK; Park SJ; Kim TM Oncotarget; 2016 Apr; 7(17):23825-36. PubMed ID: 27009864 [TBL] [Abstract][Full Text] [Related]